Search
Selected Filter
Filter Results
Displaying 41–50 of 399 diseases results
-
Aug 21, 2023
Life as a Teen with Retinitis Pigmentosa
At a mere 15 years old, Ava Ruggiero’s world shifted when she received a diagnosis of retinitis pigmentosa. As Ava continues to find balance as a student and athlete, she discusses the challenges of navigating her diagnosis alongside her parents, Joseph and Stephanie.
-
Aug 5, 2023
IZERVAY Approved by FDA for Treatment of Geographic Atrophy Secondary to Advanced Dry AMD
In two Phase 3 clinical trials, IZERVAY slowed the growth rate of lesions, the regions of cell loss in the central retina, associated with geographic atrophy (GA)
-
Jul 28, 2023
Belite Bio Doses First Patient in Phase 3 Clinical Trial for Advanced Dry AMD (GA) Therapy
The company’s emerging, oral treatment is designed to slow vision loss
-
Jul 12, 2023
PYC Doses First Patient in Clinical Trial of RNA Therapy for RP11 (PRPF31 Mutations)
The emerging RNA therapy is designed to boost expression of the PRPF31 protein
-
Jul 10, 2023
Blind Author with Usher Syndrome Ignites the Literary World
At the age of 22, Michael Garrigan received a life-changing diagnosis of Usher syndrome type 2. His vision gradually deteriorated over the years, and by the age of 45, he faced the reality of being legally blind. Determined to share his story and shed light on the capacity to triumph over darkness, Michael penned a remarkable memoir, “Ushered Out of Darkness,” in which he invites readers into his most vulnerable life moments and victories.
-
Jun 29, 2023
The five-year grant will advance the emerging treatments toward clinical trials
-
Jun 19, 2023
Beyond Labels: The Inspiring Journey of a Refsum Disease Advocate
After years of seeking answers, Alan Gunzburg was formally diagnosed with Refsum disease, a rare genetic disorder. Drawing on his unique journey, Alan sheds light on the obstacles he’s faced and how his experience motivated him to make a positive impact in the lives of others.
-
Jun 12, 2023
Beacon Therapeutics to Advance XLRP, Cone-Rod Dystrophy, and Dry AMD Gene Therapies
An emerging XLRP gene therapy acquired from AGTC is the company’s lead clinical program
-
Jun 5, 2023
Breaking Barriers as an Attorney With Usher Syndrome
Tara is a woman of extraordinary talents. A beloved twin sister, mother of two, and wife of 10 years, Tara leads a fulfilling life dedicated to advocating for others through law.
-
Jun 1, 2023
Coave Reports Encouraging Phase 1/2 Clinical Trial Results for PDE6B Gene Therapy
The company is expanding the trial to enroll younger patients with less advanced disease